14 results
·
30ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
s-Clean ScanHealing Abutment
FDA 510(k)
FDA Class 2
·Dental
NA
FDA UDI
SYNTHES (U.S.A.) LP·10886982165626·3.5MM CLAVICLE HOOK PLATE 6 HOLES LEFT-15MM HOO...
Portex
FDA UDI
ICU MEDICAL, INC.·15019517083095·
LINSCAN 808, LINSCAN 980
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
SMARTWAVE MS 2000
FDA 510(k)
FDA Class 2
·Physical Medicine
INJ. OPTIV DH, W/OEM
FDA Adverse Event
Malfunction
·LIEBEL-FLARSHEIM·Product code IZQ·August 11, 2022
DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM
FDA Adverse Event
Malfunction
·DEXCOM, INC.·Product code QBJ·August 29, 2025
ALARIS SYSTEM
FDA Adverse Event
Malfunction
·CAREFUSION SD·Product code FRN·October 27, 2023
OPTIVANTAGE DH
FDA Adverse Event
Malfunction
·LIEBEL-FLARSHEIM·Product code DXT·October 6, 2017
PUMP MMT-722NAS PRDGM INS V2.2 SK EN
FDA Adverse Event
Injury
·MEDTRONIC MINIMED·Product code LZG·November 21, 2008
MED-EL COMBI 40+ COCHLEAR IMPLANT SYSTEM
FDA Adverse Event
Malfunction
·MED-EL ELEKTROMEDIZINISCHE GERAETE, GMBH·Product code MCM·August 16, 2011
SOFLEX THREE-PIECE FOLDABLE LENS
FDA Adverse Event
Injury
·BAUSCH & LOMB, INC.·Product code HQL·April 12, 2006
EQUINOXE SHOULDER COMPONENTS
FDA Adverse Event
Injury
·EXACTECH, INC.·Product code KWT·December 8, 2023
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014